Thymoma-associated anti-AMPAR encephalitis with myasthenia gravis: a case report
Wenbin Teng, Fuzan Wei, Guiqiang Zhang, Shaodan Zhou, Ruiting Hu · 2026
Read Thymoma-associated anti-AMPAR encephalitis with myasthenia gravis: a case report by Wenbin Teng, Fuzan Wei, Guiqiang Zhang, Shaodan Zhou, Ruiting Hu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13124712.txt.
Description
A peer-reviewed research article from Europe PMC (2026). BackgroundThymoma can trigger a spectrum of paraneoplastic neurological disorders, including autoimmune encephalitis (AE) and myasthenia gravis (MG). However, the sequential development of anti-α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor (AMPAR) autoimmune encephalitis followed by MG in the same patient is rarely reported.ObjectiveTo describe the clinical presentation, diagnostic work-up, treatment response, and outcome of a patient who developed thymoma-associated anti-AMPAR encephalitis and later presented with MG.MethodsWe retrospectively reviewed the medical records, imaging findings, laboratory results, and treatment course of a 49-year-old man who was evaluated at our
Catalog record
| CREATOR | Wenbin Teng, Fuzan Wei, Guiqiang Zhang, Shaodan Zhou, Ruiting Hu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 25 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |